added today19 Oct 2016 00:17
glutton for punishment, lol, sigh.
this is pretty frustrating, tbh.
but i think there may now be a pricing
opportunity, linked with the s/t fears in
the investor community about effects
of a clinton win on pharma pricing.
i think clinton will probably win, but
doubt she will be that fierce with big
pharma or new development pharma,
rather she will target smaller players
who are trying to price gouge on
products which are already developed
& being traded between pharma cos.
companies on the inter-co market.
i'm also thinking that £ fall may be
providing an opportunity.... WPCT
owns stakes in a fair few UK small
companies, but where the value, *if*
there really is long-term value (!) resides
in the intellectual property potential
which will be valuable in the wider
international markets (& potentially
floated / sold off in these) rather than
simply in domestic ££ denominated.
might turn out to be entirely wrong,
and hinges a lot whether woody &
team are actually picking some
decent IP prospects, but anyway,
in for penny, in for pound, added.
(not in hope of any short-term rise!)